Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Berry-Kravis

Showing results (51-60 of 265) with videos related to

Pageof 27
Sort By:
Proteomics Insights|March 12, 2019
Expression and Characterization of Human Fragile X Mental Retardation Protein Isoforms and Interacting Proteins in Human CellsJiang Zhang, Guangli Wang, Wei-Wu He, et al.
Journal of Neurodevelopmental Disorders|September 11, 2012
Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS)Andrew Knox, Andrea Schneider, Floridette Abucayan, et al.
American Journal on Intellectual and Developmental Disabilities|October 16, 2010
Seizures in fragile X syndrome: characteristics and comorbid diagnosesElizabeth Berry-Kravis, Melissa Raspa, Lisa Loggin-Hester, et al.
Developmental Psychobiology|May 7, 2011
Autonomic regulation in fragile X syndromeKeri J Heilman, Emily R Harden, Danielle M Zageris, et al.
Journal of Neurodevelopmental Disorders|November 9, 2016
Developmental profiles of infants with an <i>FMR1</i> premutationAnne C Wheeler, John Sideris, Randi Hagerman, et al.
Experimental Brain Research|June 22, 2023
Atypical vocal quality in women with the FMR1 premutation: an indicator of impaired sensorimotor controlLaura Friedman, Meagan Lauber, Roozbeh Behroozmand, et al.
Annals of Neurology|May 6, 2003
Tremor and ataxia in fragile X premutation carriers: blinded videotape studyElizabeth Berry-Kravis, Foster Lewin, Joanne Wuu, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|September 18, 2013
Outcome measures for clinical trials in fragile X syndromeElizabeth Berry-Kravis, David Hessl, Leonard Abbeduto, et al.
Journal of Alzheimer'S Disease : JAD|January 20, 2026
Cognitive dysfunction in women with the <i>FMR1</i> premutation during midlife: The LASSI-L reveals curvilinear CGG-dependent risk buffered by college educationJessica Klusek, Jillian Gierman, Amanda J Fairchild, et al.
Brain and Cognition|March 13, 2022
Verbal inhibition declines among older women with high FMR1 premutation expansions: A prospective studyNell Maltman, Jessica Klusek, Leann DaWalt, et al.
Pageof 27

Showing results (51-60 of 265) with videos related to

Sort By:
Pageof 27
Proteomics Insights|March 12, 2019
Expression and Characterization of Human Fragile X Mental Retardation Protein Isoforms and Interacting Proteins in Human CellsJiang Zhang, Guangli Wang, Wei-Wu He, et al.
Journal of Neurodevelopmental Disorders|September 11, 2012
Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS)Andrew Knox, Andrea Schneider, Floridette Abucayan, et al.
American Journal on Intellectual and Developmental Disabilities|October 16, 2010
Seizures in fragile X syndrome: characteristics and comorbid diagnosesElizabeth Berry-Kravis, Melissa Raspa, Lisa Loggin-Hester, et al.
Developmental Psychobiology|May 7, 2011
Autonomic regulation in fragile X syndromeKeri J Heilman, Emily R Harden, Danielle M Zageris, et al.
Journal of Neurodevelopmental Disorders|November 9, 2016
Developmental profiles of infants with an <i>FMR1</i> premutationAnne C Wheeler, John Sideris, Randi Hagerman, et al.
Experimental Brain Research|June 22, 2023
Atypical vocal quality in women with the FMR1 premutation: an indicator of impaired sensorimotor controlLaura Friedman, Meagan Lauber, Roozbeh Behroozmand, et al.
Annals of Neurology|May 6, 2003
Tremor and ataxia in fragile X premutation carriers: blinded videotape studyElizabeth Berry-Kravis, Foster Lewin, Joanne Wuu, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|September 18, 2013
Outcome measures for clinical trials in fragile X syndromeElizabeth Berry-Kravis, David Hessl, Leonard Abbeduto, et al.
Journal of Alzheimer'S Disease : JAD|January 20, 2026
Cognitive dysfunction in women with the <i>FMR1</i> premutation during midlife: The LASSI-L reveals curvilinear CGG-dependent risk buffered by college educationJessica Klusek, Jillian Gierman, Amanda J Fairchild, et al.
Brain and Cognition|March 13, 2022
Verbal inhibition declines among older women with high FMR1 premutation expansions: A prospective studyNell Maltman, Jessica Klusek, Leann DaWalt, et al.
Pageof 27